STERIS is a global leader in infection prevention, contamination control, surgical technologies, and more.
STERIS is the world’s pre-eminent infection prevention, decontamination, and surgical and critical care company, with a long list of first-to-market products and industry-leading service innovations and thousands of customers in more than 60 countries.
While the corporation was founded as Innovative Medical Technologies in 1985 and renamed STERIS in 1987, our history dates back to 1894 with the founding of American Sterilizer Company, a long-time, global leading innovator of sterilization products.
Today, through a series of strategic acquisitions and continual innovation of new products, STERIS holds one of the broadest portfolios of products in the industry. It stands at the forefront of efforts to prevent infection and contamination in healthcare and pharmaceutical environments, and is broadening its reach with products to meet the needs of defense and industrial markets.

Mentor, US
Size (employees)
14,000 (est)
STERIS was founded in 1987 and is headquartered in Mentor, US

STERIS Office Locations

STERIS has an office in Mentor
Mentor, US (HQ)
5960 Heisley Rd
Mentor, US
9260 Progress Pkwy

STERIS Metrics

STERIS Financial Metrics

Revenue (2016)

$2.2 b

Gross profit

$895.5 m

Gross profit margin (2016), %


Net income (2016)

$111.6 m

Market capitalization (21-Mar-2017)

$5.8 b

Closing share price (21-Mar-2017)


Cash (31-Mar-2015)

$167.7 m
STERIS's current market capitalization is $5.8 b.
STERIS's revenue was reported to be $2.2 b in FY, 2016
FY, 2016


$2.2 b

Gross profit

$895.5 m

Gross profit Margin, %


Operating expense total

$682.6 m


$212.9 m

EBIT margin, %


Net Income

$111.6 m
FY, 2014FY, 2015


$152.8 m$167.7 m

Accounts Receivable

$313.7 m$325.3 m


$37 m$35 m

Current Assets

$674.7 m$720.4 m


$454.4 m$493.1 m

Total Assets

$1.9 b$2.1 b

Accounts Payable

$102.4 m$99.3 m

Current Liabilities

$254.5 m$283.3 m

Retained Earnings

$1.1 b$1.2 b

Total Equity

$1 b$1.1 b

Financial Leverage

1.8 x2 x
FY, 2014FY, 2015FY, 2016

Net Income

$129.4 m$135.1 m

Accounts Receivable

($29 m)($2.8 m)


Accounts Payable

$19.4 m($3.1 m)

Cash From Operating Activities

$209.6 m$246 m$81.2 m

Cash From Investing Activities

($148.7 m)($283.8 m)

Long-term Borrowings

($70 m)

STERIS Market Value History

STERIS Median Salaries

Source: 46 public H-1B filings from STERIS

STERIS Online Presence

STERIS Company Life

You may also be interested in